Bayer and MS Technologies receive approval for Balance™ GT Soybean technology in European Union
Research Triangle Park, N.C. (July 22, 2016)
Bayer and MS Technologies L.LC. have achieved a milestone on their path to delivering new solutions for soybean growers. The dual herbicide tolerance trait Balance™ GT (Event FG72) received a positive scientific opinion from EU Food Safety Authority (EFSA) which was subsequently accepted by the European Commission for the importation of Balance™ GT soybeans for food and feed uses. This follows approvals received already from the U.S, Canada, and Brazil for cultivation, and is near completion of receiving all key required import approvals globally.
The Balance™ GT trait confers tolerance to both isoxaflutole (an HPPD inhibitor) and glyphosate herbicides and is intended to be an important tool for weed control and herbicide resistance management. The first launch is planned for the U.S. in 2017, pending final key import approvals.
Balance™ GT is owned by MS Technologies and is being co-developed through a joint development agreement between MS Technologies and Bayer.
“The new Balance™ GT Soybean Performance System is intended to address the weed management challenges faced by soybean farmers,” said Frank Terhorst, head of the Seeds business unit of Bayer’s Crop Science division. “Farmers will benefit from effective cross-spectrum weed control and an excellent weed resistance management tool. We are pleased with the progress we are making on the regulatory front for Balance™ GT.”
“Resistance to herbicides is a global challenge demanding new solutions. The dual modes of action in Balance™ GT soybeans are intended to help soybean growers by providing flexibility in weed management,” said Joseph Merschman, president of MS Technologies. “We are well on track to deliver this technology in high-yielding, best-in-class soybean varieties developed by MS Technologies.”
Bayer and MS Technologies have been collaborating since 2007 with new herbicide tolerance technologies for soybeans.
Currently, more than 90 percent of soybeans grown in the United States are genetically modified and tolerant to either glyphosate or glufosinate (Liberty®) herbicides. Balance™ GT is expected to be one of the key dual-herbicide tolerant products for soybeans on the market in the U.S. and an important alternative to current herbicide options.
Balance® Bean is an isoxaflutole-based herbicide, which upon a registration is expected to be the first HPPDi (Group 27) herbicide available for use in soybeans. At this time Balance® Bean is not approved for use on soybeans. Upon registration of Balance® Bean, Bayer will make more information about the product available.
About MS Technologies™
MS Technologies™ LLC is a leading trait, technology and soybean genetics provider. MS Technologies™ features a portfolio of in-house traits, as well as wide access to other traits and technologies through collaborative agreements with other parties. For more information on MS Technologies™, visit our website.
Bayer: Science For A Better Life
Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2015, the Group employed around 117,000 people and had sales of EUR 46.3 billion. Capital expenditures amounted to EUR 2.6 billion, R&D expenses to EUR 4.3 billion. These figures include those for the high-tech polymers business, which was floated on the stock market as an independent company named Covestro on October 6, 2015. For more information, go to www.bayer.com.